15 results
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(xli)Cybersecurity; Data Protection
8-K
EX-1.2
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(xliii)Cybersecurity; Data Protection. (A) There has been
10-K
8mf8flud87r42a
22 Mar 19
Annual report
4:45pm
424B4
wktkjoq gxrscxt0
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
43aidr
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
ytwenn
23 Jan 19
IPO registration (amended)
4:39pm
S-1
pt69fatp0xg8 5u9
21 Dec 18
IPO registration
4:39pm
DRS/A
o9y o1ccxo79fjb9f
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
3ddanvb dj
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next